EyePoint Pharmaceuticals, Inc. (EYPT) Social Stream
EYEPOINT PHARMACEUTICALS INC (EYPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EYPT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 3 | $25 | $15 | $20.666 | $6.15 | 236.03% |
| 2021-11-15 | 3 | $35 | $15 | $27 | $6.15 | 339.02% |
| 2022-02-14 | 2 | $35 | $24 | $30 | $6.15 | 387.8% |
| 2022-06-22 | 3 | $35 | $24 | $30 | $6.15 | 387.8% |
| 2022-08-02 | 4 | $35 | $21 | $27.75 | $6.15 | 351.22% |
| 2022-11-03 | 4 | $35 | $21 | $28 | $6.15 | 355.28% |
| 2023-03-03 | 4 | $52 | $21 | $32.8 | $6.15 | 433.33% |
| 2023-03-05 | 5 | $52 | $21 | $32.8 | $6.15 | 433.33% |
| 2023-04-24 | 6 | $52 | $21 | $32.833 | $6.15 | 433.87% |
| 2023-05-19 | 6 | $52 | $21 | $32 | $6.15 | 420.33% |
| 2023-05-21 | 6 | $52 | $22 | $32.5 | $6.15 | 428.46% |
| 2023-08-03 | 6 | $55 | $22 | $33 | $6.15 | 436.59% |
| 2023-11-03 | 7 | $55 | $20 | $30.857 | $6.15 | 401.74% |
The Trend in the Analyst Price Target
EYPT's average price target has moved up $11.75 over the prior 27 months.
Over the past 35 weeks, EYPT's average upside potential has been 474.54%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-05 | 5 | 52 | 21 | 32.800 | 3.26 | 906.13% |
| 2023-05-21 | 6 | 55 | 22 | 33.000 | 6.50 | 407.69% |
| 2023-06-06 | 6 | 55 | 22 | 33.000 | 6.49 | 408.47% |
| 2023-07-28 | 6 | 55 | 22 | 33.000 | 11.84 | 178.72% |
| 2023-11-03 | 7 | 55 | 20 | 30.833 | 7.75 | 297.85% |
EYPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 15 months, EYPT's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how EYEPOINT PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1267.42% of that group.
- To contextualize these metrics, consider that out of all US stocks, EYEPOINT PHARMACEUTICALS INC's number of analysts covering the stock is greater than 270.25% of them.
- To contextualize these metrics, consider that out of Measuring and Control Equipment stocks, EYEPOINT PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1047.14% of them.
- EYEPOINT PHARMACEUTICALS INC's average analyst price target is higher than 276.58% of Measuring and Control Equipment stocks.
In the Measuring and Control Equipment industry, LAB, HBIO, and AXDX are the three stocks most similar to EYEPOINT PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is EYPT a Buy, Hold or Sell? See the POWR Ratings now!